134 related articles for article (PubMed ID: 22040828)
1. [Frontiers in vitamin D; Basic research and clinical application. Effect of eldecalcitol on bone structure].
Ito M
Clin Calcium; 2011 Nov; 21(11):119-25. PubMed ID: 22040828
[TBL] [Abstract][Full Text] [Related]
2. [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
Endo I; Matsumoto T
Clin Calcium; 2011 Nov; 21(11):103-10. PubMed ID: 22040826
[TBL] [Abstract][Full Text] [Related]
3. [Frontiers in vitamin D; Basic research and clinical application. The effects of eldecalcitol on bone mineral density and fracture prevention--Post hoc analysis].
Hagino H
Clin Calcium; 2011 Nov; 21(11):111-8. PubMed ID: 22040827
[TBL] [Abstract][Full Text] [Related]
4. Effect of eldecalcitol, an active vitamin D analog, on hip structure and biomechanical properties: 3D assessment by clinical CT.
Ito M; Nakamura T; Fukunaga M; Shiraki M; Matsumoto T
Bone; 2011 Sep; 49(3):328-34. PubMed ID: 21605716
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic imaging of treatment in osteoporosis; new active vitamin D].
Shiraishi A; Ito M
Clin Calcium; 2011 Jul; 21(7):1057-66. PubMed ID: 21719987
[TBL] [Abstract][Full Text] [Related]
6. [Frontiers in vitamin D; basic research and clinical application. Inhibitory effects of eldecalcitol, an active vitamin D derivative, on bone resorption in vivo].
Harada S; Mizoguchi T; Takahashi N
Clin Calcium; 2011 Nov; 21(11):91-8. PubMed ID: 22040825
[TBL] [Abstract][Full Text] [Related]
7. A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures--a randomized, active comparator, double-blind study.
Matsumoto T; Ito M; Hayashi Y; Hirota T; Tanigawara Y; Sone T; Fukunaga M; Shiraki M; Nakamura T
Bone; 2011 Oct; 49(4):605-12. PubMed ID: 21784190
[TBL] [Abstract][Full Text] [Related]
8. Eldecalcitol for the treatment of osteoporosis.
Matsumoto T; Endo I
Drugs Today (Barc); 2012 Mar; 48(3):189-96. PubMed ID: 22462038
[TBL] [Abstract][Full Text] [Related]
9. Eldecalcitol: newly developed active vitamin D(3) analog for the treatment of osteoporosis.
Hagino H
Expert Opin Pharmacother; 2013 Apr; 14(6):817-25. PubMed ID: 23477453
[TBL] [Abstract][Full Text] [Related]
10. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
Saito H; Takeda S; Amizuka N
J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
[TBL] [Abstract][Full Text] [Related]
11. [Frontiers in vitamin D; basic Research and clinical application. Effect of active vitamin D3 on osteoporosis].
Yamauchi M; Sugimoto T
Clin Calcium; 2011 Nov; 21(11):17-24. PubMed ID: 22040817
[TBL] [Abstract][Full Text] [Related]
12. Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
Smith SY; Doyle N; Boyer M; Chouinard L; Saito H
Bone; 2013 Nov; 57(1):116-22. PubMed ID: 23774444
[TBL] [Abstract][Full Text] [Related]
13. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
[TBL] [Abstract][Full Text] [Related]
14. [Frontiers in vitamin D; basic research and clinical application. A review on histological findings in bones administered with eldecalcitol].
Hongo H; Sasaki M; Hasegawa T; Amizuka N
Clin Calcium; 2011 Nov; 21(11):63-70. PubMed ID: 22040822
[TBL] [Abstract][Full Text] [Related]
15. Eldecalcitol improves mechanical strength of cortical bones by stimulating the periosteal bone formation in the senescence-accelerated SAM/P6 mice - a comparison with alfacalcidol.
Shiraishi A; Sakai S; Saito H; Takahashi F
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():119-23. PubMed ID: 24189542
[TBL] [Abstract][Full Text] [Related]
16. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
Reginster JY; Lecart MP; Richy F
J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
[TBL] [Abstract][Full Text] [Related]
17. Effect of ovariectomy, malnutrition and glucocorticoid application on bone properties in sheep: a pilot study.
Lill CA; Fluegel AK; Schneider E
Osteoporos Int; 2002; 13(6):480-6. PubMed ID: 12107662
[TBL] [Abstract][Full Text] [Related]
18. [Current Topics on Vitamin D. Treatment of osteoporosis with eldecalcitol: Its therapeutic efficacy and adverse effect on renal function].
Takeuchi Y
Clin Calcium; 2015 Mar; 25(3):425-32. PubMed ID: 25716816
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
Matsumoto T; Takano T; Yamakido S; Takahashi F; Tsuji N
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):261-4. PubMed ID: 20298784
[TBL] [Abstract][Full Text] [Related]
20. Independent and combined contributions of cancellous and cortical bone deficits to vertebral fracture risk in postmenopausal women.
Qiu S; Rao DS; Palnitkar S; Parfitt AM
J Bone Miner Res; 2006 Nov; 21(11):1791-6. PubMed ID: 17002584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
